Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2004-004217-42-AT
EUCTR2004-004217-42-AT
Active, not recruiting
Not Applicable

Injektion von Botulinum Toxin in den Pylorus zur Behandlung von Chronic Upper Gastrointestinal Symptoms bei Diabetic Patients mit verzögerter Gastric Emptying

AKH Wien0 sites140 target enrollmentMarch 22, 2005
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsDiabetes mellitus
DrugsBotoxDysport

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetes mellitus
Sponsor
AKH Wien
Enrollment
140
Status
Active, not recruiting
Last Updated
10 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 22, 2005
End Date
TBD
Last Updated
10 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
AKH Wien

Eligibility Criteria

Inclusion Criteria

  • •Diabetic gastroparesis
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •no diabetic gastroparesis

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Intragastrale Injektion von Botulinum Toxin A zur Behandlung der AdipositasDie morbide Adipositas nimmt in westlichen Ländern stetig zu. In Österreich und Deutschland sind ca. 30% der Erwachsenen übergewichtig und 1% (900.000 Erwachsene) morbid adipös. In den USA stellt die Adiposita ein schwerwiegendes gesundheitliches Problem dar. Geschätzte 60% der Amerikaner sind übergewichtig und über 6% (12 Millionen) morbid adipös.
EUCTR2005-001095-13-ATMedical University Innsbruck20
Completed
Not Applicable
Subepithelial injection of botulinum toxin A for non-neurogecic overactive bladderon-neurogenic overactive bladder
JPRN-UMIN000001422ational Center for Geriatrics & Gerontology45
Completed
Not Applicable
Subepithelial injection of botulinum toxin A for neurogecic detrusor overactivity (NDO) due to spinal cord injuryeurogenic detrusor overactivity
JPRN-UMIN000001421ational Center for Geriatrics & Gerontology26
Not yet recruiting
Not Applicable
Effectiveness of Botulinum Toxin Infiltration for treatment of upper limb dysfunctions after treatment for breast cancer.Patients treated for breast cancer and chronic pain (> 3 months) at the breast region
NL-OMON26807Z Leuven50
Active, not recruiting
Phase 1
Effectiveness of botox injections in the pectoral muscles for treatment of upper limb dysfunctions after breast cancer treatment
EUCTR2014-005114-33-BEZ Leuven50